Drugs and Devices

FDA approves new treatment for bladder cancer

On May 18, the U.S. the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) to treat urothelial carcinoma. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares